Please assess the completion status of the following clinical trial:

Trial Title: A Study of Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adult patients, 18-70 years of age;~* glioblastoma, confirmed histologically;~* no previous chemotherapy or radiotherapy for glioblastoma;~* non-methylated MGMT promoter in the tumor.~Exclusion Criteria:~* prior systemic treatment for glioblastoma multiforme;~* prior treatment with Avastin;~* significant cardiovascular disease;~* other active malignant disease.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).